XRN Strangle Strategy
XRN (Chiron Real Estate Inc.), in the Financial Services sector, (REIT - Industrial industry), listed on NYSE.
Global Medical REIT, Inc. engages in the acquisition of purpose-built healthcare facilities and the leasing of those properties to healthcare systems and physician groups. The company was founded on March 18, 2011 and is headquartered in Bethesda, MD.
XRN (Chiron Real Estate Inc.) trades in the Financial Services sector, specifically REIT - Industrial, with a market capitalization of approximately $454.2M, a beta of 1.14 versus the broader market, a 52-week range of 29.05-39.93, average daily share volume of 141K, a public-listing history dating back to 2016, approximately 26 full-time employees. These structural characteristics shape how XRN stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.14 places XRN roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline. XRN pays a dividend, which adjusts put-call parity and shifts the ex-dividend pricing across the listed chain.
What is a strangle on XRN?
A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money.
Current XRN snapshot
As of May 15, 2026, spot at $33.83, ATM IV 27.60%, expected move 7.91%. The strangle on XRN below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this strangle structure on XRN specifically: IV rank is unavailable in the current snapshot, so regime-based timing for XRN is inferred from ATM IV at 27.60% alone, with a market-implied 1-standard-deviation move of approximately 7.91% (roughly $2.68 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated XRN expiries trade a higher absolute premium for lower per-day decay. Position sizing on XRN should anchor to the underlying notional of $33.83 per share and to the trader's directional view on XRN stock.
XRN strangle setup
The XRN strangle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With XRN near $33.83, the first option leg uses a $35.52 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed XRN chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 XRN shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $35.52 | N/A |
| Buy 1 | Put | $32.14 | N/A |
XRN strangle risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit.
XRN strangle payoff curve
Modeled P&L at expiration across a range of underlying prices for the strangle on XRN. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use strangle on XRN
Strangles on XRN are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the XRN chain.
XRN thesis for this strangle
The market-implied 1-standard-deviation range for XRN extends from approximately $31.15 on the downside to $36.51 on the upside. A XRN long strangle is the OTM cousin of the straddle: lower up-front cost but the underlying has to travel further past either OTM strike before the position turns profitable at expiration. As a Financial Services name, XRN options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to XRN-specific events.
XRN strangle positions are structurally neutral / high-volatility (long premium, OTM); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. XRN positions also carry Financial Services sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move XRN alongside the broader basket even when XRN-specific fundamentals are unchanged. Always rebuild the position from current XRN chain quotes before placing a trade.
Frequently asked questions
- What is a strangle on XRN?
- A strangle on XRN is the strangle strategy applied to XRN (stock). The strategy is structurally neutral / high-volatility (long premium, OTM): A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money. With XRN stock trading near $33.83, the strikes shown on this page are snapped to the nearest listed XRN chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are XRN strangle max profit and max loss calculated?
- Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the XRN strangle priced from the end-of-day chain at a 30-day expiry (ATM IV 27.60%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a XRN strangle?
- The breakeven for the XRN strangle priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current XRN market-implied 1-standard-deviation expected move is approximately 7.91%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a strangle on XRN?
- Strangles on XRN are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the XRN chain.
- How does current XRN implied volatility affect this strangle?
- Current XRN ATM IV is 27.60%; IV rank context is unavailable in the current snapshot.